1. Academic Validation
  2. Directional homing of glycosylation-modified bone marrow mesenchymal stem cells for bone defect repair

Directional homing of glycosylation-modified bone marrow mesenchymal stem cells for bone defect repair

  • J Nanobiotechnology. 2021 Jul 31;19(1):228. doi: 10.1186/s12951-021-00969-3.
Long Chen  # 1 Wei Luo  # 1 Yuanzheng Wang  # 1 Xiongbo Song 1 Senlei Li 1 Jun Wu 2 Li Sun 3
Affiliations

Affiliations

  • 1 Department of Orthopedics, Guizhou Provincial People's Hospital, Guiyang, 550000, Guizhou, People's Republic of China.
  • 2 Guangdong Provincial Key Laboratory of Sensor Technology and Biomedical Instruments, School of Biomedical Engineering, Sun Yat-Sen University, Shenzhen, 518107, People's Republic of China. wujun29@mail.sysu.edu.cn.
  • 3 Department of Orthopedics, Guizhou Provincial People's Hospital, Guiyang, 550000, Guizhou, People's Republic of China. lisun@gzu.edu.cn.
  • # Contributed equally.
Abstract

Background: One of the greatest challenges for tissue-engineered bone is the low survival rate of locally grafted cells. The cell homing technology can effectively increase the number of these grafted cells, therefore, enhancing the repair of bone defects. Here we explore the effect of fucosylation modification on the directional homing of bone marrow mesenchymal stem cells (BMSCs) and their ability to repair bone defects.

Results: Glycosylated BMSCs expressed high levels of the Sialyl Lewis-X (sLeX) antigen, which enabled the cells to efficiently bind to E- and P-selectins and to home to bone defect sites in vivo. Micro-CT and histological staining results confirmed that mice injected with FuT7-BMSCs showed an improved repair of bone defects compared to unmodified BMSCs.

Conclusions: The glycosylation modification of BMSCs has significantly enhanced their directional homing ability to bone defect sites, therefore, promoting bone repair. Our results suggest that glycosylation-modified BMSCs can be used as the source of the cells for the tissue-engineered bone and provide a new approach for the treatment of bone defects.

Keywords

Bone defect repair; Bone marrow mesenchymal stem cells; Directional homing; Glycosylation.

Figures
Products